Skip to main content
Sheila Barbarino on Muck Rack

Sheila Barbarino

Hermosa Beach
As seen in: Wiley Online Library, Journal of The American Academy of Dermatology (JAAD), Modern Aesthetics
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sheila

Contact Sheila, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

EYE‐CODE Protocol for the Nonophthalmologist for Treatment of Retinal Artery Occlusion After Intra‐Arterial Injection of Soft‐Tissue Fillers: 2025 Update

|
By Sheila Barbarino, Saami Khalifian, John Fezza
| Wiley Online Library Verified
1 Introduction Retinal artery occlusion after a soft-tissue filler procedure is a rare event. The incidence has, however, increased in the past 5 years, most likely as a result of the everincreasing popularity of filler injections and the varied skill level of injectors. In a 2024 review of the worldwide literature, case reports had risen from a total of 146 to 511 cases over the 5-year period from 2018 to 2023 [1].
Open in Who Shared Issue with article?

Galderma Seeks to Address Facial Volume Loss From GLP-1 Medications with Injectable Portfolio

|
By Sheila Barbarino, Hiren Kolli
| Modern Aesthetics Verified
Galderma announced positive first results last week from a trial designed to explore the benefits of Restylane Lyft or Contour in combination with Sculptra in patients with medication-drive weight loss with associated facial volume loss.
Open in Who Shared Issue with article?

Illuminate PRP Adds Industry Veteran Redmond as CCO

|
By Sheila Barbarino, Hiren Kolli
| Modern Aesthetics Verified
Industry veteran Jennifer Redmond, MBA, joined Illuminate PRP as Chief Commercial Officer, the company announced. “Jennifer brings a wealth of experience in sales and marketing within the aesthetics and pharmaceutical industries, along with strong leadership and a commitment to driving positive change,” CEO Jayson Jonsson said in a LinkedIn post.
Open in Who Shared Issue with article?
See all 18 articles